Evidence map›Paper›PMID 26887054›Full record

ArticleOncotarget2016

Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.

Davide Degli Esposti, Hector Hernandez-Vargas, Catherine Voegele, Nora Fernandez-Jimenez, Nathalie Forey, Brigitte Bancel, Florence Le Calvez-Kelm, James McKay, Philippe Merle, Zdenko Herceg

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Pooled it
  2. Article
  3. Review
  4. Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism.Drug metabolism and disposition: the biological fate of chemicals · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Davide Degli EspostiEpigenetics Group, International Agency for Research on Cancer (IARC), Lyon, France.
Hector Hernandez-VargasEpigenetics Group, International Agency for Research on Cancer (IARC), Lyon, France.
Catherine VoegeleGenetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC), Lyon, France.
Nora Fernandez-JimenezEpigenetics Group, International Agency for Research on Cancer (IARC), Lyon, France.
Nathalie ForeyGenetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC), Lyon, France.
Brigitte BancelCentre de Recherche en Cancérologie de Lyon, UMR INSERM 1052, CNRS 5286, Lyon Cedex, France.
Florence Le Calvez-KelmGenetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC), Lyon, France.
James McKayGenetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC), Lyon, France.
Philippe MerleCentre de Recherche en Cancérologie de Lyon, UMR INSERM 1052, CNRS 5286, Lyon Cedex, France.
Zdenko HercegEpigenetics Group, International Agency for Research on Cancer (IARC), Lyon, France.
Centre International de Recherche sur le Cancer · FRCentre National de la Recherche Scientifique · FRHospices Civils de Lyon · FR

Funding

World Health Organization 001
6 · The paper itself

Abstract

Functional characterization of long non-coding RNAs (lncRNAs) and their pathological relevance is still a challenging task. Abnormal expression of a few long non-coding RNAs have been found associated with hepatocellular carcinoma, with potential implications to both improve our understanding of molecular mechanism of liver carcinogenesis and to discover biomarkers for early diagnosis or therapy. However, the understanding of the global role of lncRNAs during HCC development is still in its infancy. In this study, we produced RNA-Seq data from 23 liver tissues (controls, cirrhotic and HCCs) and applied statistical and gene network analysis approaches to identify and characterize expressed lncRNAs. We detected 5,525 lncRNAs across different tissue types and identified 57 differentially expressed lncRNAs in HCC compared with adjacent non-tumour tissues using stringent criteria (FDR<0.05, Fold Change>2). Using weighted gene co-expression network analysis (WGCNA), we found that differentially expressed lncRNAs are co-expressed with genes involved in cell cycle regulation, TGF-β signalling and liver metabolism. Furthermore, we found that more than 20% of differentially expressed lncRNAs are associated to actively transcribed enhancers and that the co-expression patterns with their closest genes change dramatically during HCC development. Our study provides the most comprehensive compendium of lncRNAs expressed in HCC, as well as in control or cirrhotic livers. Our results identified both known oncogenic lncRNAs (such as H19 and CRNDE) and novel lncRNAs involved in cell cycle deregulation and liver metabolism deficits occurring during HCC development.

Indexed as

Gene Expression Regulation, NeoplasticSequence Analysis, RNAAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, HepatocellularFemaleGene Expression ProfilingGene Regulatory NetworksHumansLiver NeoplasmsMaleMiddle AgedRNA, Long NoncodingRNA, NeoplasmBiomarkers, TumorRNA, Long NoncodingRNA, Neoplasmenhancer-associated RNAsgene networkshepatocellular carcinomalong non-coding RNARNA-sequencing

Identifiers

PMID26887054
PMCPMC5077982
OpenAlexW2285675605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.